Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 activity in vivo limits glucocorticoid exposure to human adipose tissue and decreases lipolysis.
CONTEXT: The pathophysiological importance of glucocorticoids (GCs) is exemplified by patients with Cushing's syndrome who develop hypertension, obesity, and insulin resistance. At a cellular level, availability of GCs to the glucocorticoid and mineralocorticoid receptors is controlled by the i...
Main Authors: | Tomlinson, J, Sherlock, M, Hughes, B, Hughes, S, Kilvington, F, Bartlett, W, Courtney, R, Rejto, P, Carley, W, Stewart, P |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2007
|
Similar Items
-
The functional consequences of 11beta-hydroxysteroid dehydrogenase expression in adipose tissue.
by: Tomlinson, J, et al.
Published: (2002) -
Cortisol metabolism and the role of 11beta-hydroxysteroid dehydrogenase.
by: Tomlinson, J, et al.
Published: (2001) -
11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response.
by: Tomlinson, J, et al.
Published: (2004) -
11beta-hydroxysteroid dehydrogenase type 1 regulates glucocorticoid-induced insulin resistance in skeletal muscle.
by: Morgan, SA, et al.
Published: (2009) -
Cerebrospinal fluid production - A role for 11 beta-hydroxysteroid dehydrogenase type 1?
by: Rauz, S, et al.
Published: (2004)